Chemomab Therapeutics
CMMB | NASDAQ
$1.62
+$0.09 (+5.88%)
At close: Nov 16, 2026, 4:00 PM ET
$1.62
$0.00 (+0.15%)
After-hours:
Nov 16, 2026, 5:32 PM ET
Chemomab Therapeutics Statistics
Key statistics explainedMarket Data
$12.96M
$6.28M
0.66
141.22K
8M
38.13%
4.75%
NASDAQ
US16385C2035
Price Performance
28.6%
-15.6%
0.0%
-1.8%
-37.7%
-28.9%
-95.8%
28.6%
-39.1%
-47.6%
-54.5%
Valuation
-1.59
N/A
-0.02
0.02
N/A
0.40
1.49
-1.16
-1.15
-1.16
N/A
-0.79
-0.79
-0.56
-63.0%
-86.5%
-87.2%
Financial Health
$6.69M
$0
$6.69M
$10.24M
6.41
6.41
0.00
-0.00
-0.00
N/A
0.00
-12.65
1
Margins & Profitability
0.0%
0.0%
0.0%
0.0%
N/A
N/A
0.0%
-0.8%
Returns
-74.3%
-70.8%
-91.7%
-91.7%
-74.3%
Historical Growth (CAGR)
N/A
N/A
N/A
142.9%
33.7%
19.4%
-16.2%
27.2%
-7.5%
Analyst Forecasts
Hold
0
32.0%
N/A
Mar 10, 2027
-$0.01
-95.8%
N/A
N/A
Fair Value Estimates
N/A
N/A
N/A
N/A
$0.00
N/A
Cash Flow
$-11.22M
$-11.22M
$-11.31M
-$1.40
-$1.40
0.0%
Income Statement
$0
$0
$-7.96M
$-7.91M
$-7.6M
-$1.02
N/A
$-633.49K
12
Add to Watchlist
Select watchlists to add or remove CMMB